240P Effect of dose intensity (DI) of palbociclib (PAB) and initial body weight dosage (BWD) on progression free survival (PFS): A real-world data analysis in patients with hormone-receptor (HR) positive HER2 negative metastatic breast cancer (MBC)
| Autor: | Penabad, S. Recalde, Fort, E., Otero, S., Lezcano, C., Gil, V.L. Obadia, Sabaté, N., Juher, H. Pla, Falgas, E. Felip, Vila, M. Margeli, Villaro, G. Vinas, Gomez, A.M. Esteve, Rey, M., Simon, S. Pernas, Fontanals, S. |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|